Bausch Health Cos EBITDA Margin 2010-2024 | BHC

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Bausch Health Cos (BHC) over the last 10 years. The current EBITDA margin for Bausch Health Cos as of September 30, 2024 is .
Bausch Health Cos EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $9.47B $2.69B 28.44%
2024-06-30 $9.20B $2.42B 26.34%
2024-03-31 $8.97B $2.40B 26.79%
2023-12-31 $8.76B $2.29B 26.17%
2023-09-30 $8.54B $1.72B 20.09%
2023-06-30 $8.35B $1.97B 23.64%
2023-03-31 $8.15B $1.79B 22.00%
2022-12-31 $8.12B $1.95B 23.97%
2022-09-30 $8.13B $2.56B 31.51%
2022-06-30 $8.19B $2.93B 35.80%
2022-03-31 $8.33B $2.52B 30.28%
2021-12-31 $8.43B $2.06B 24.39%
2021-09-30 $8.45B $1.75B 20.74%
2021-06-30 $8.48B $1.69B 19.92%
2021-03-31 $8.04B $2.01B 25.03%
2020-12-31 $8.03B $2.56B 31.92%
2020-09-30 $8.04B $1.55B 19.32%
2020-06-30 $8.11B $1.51B 18.62%
2020-03-31 $8.60B $1.84B 21.44%
2019-12-31 $8.60B $1.94B 22.50%
2019-09-30 $8.50B $3.09B 36.40%
2019-06-30 $8.43B $3.07B 36.38%
2019-03-31 $8.40B $2.82B 33.59%
2018-12-31 $8.38B $0.51B 6.13%
2018-09-30 $8.42B $0.47B 5.63%
2018-06-30 $8.51B $0.41B 4.77%
2018-03-31 $8.61B $0.71B 8.26%
2017-12-31 $8.72B $3.11B 35.66%
2017-09-30 $8.96B $3.45B 38.48%
2017-06-30 $9.22B $2.56B 27.71%
2017-03-31 $9.41B $2.53B 26.86%
2016-12-31 $9.67B $2.42B 24.99%
2016-09-30 $10.03B $2.42B 24.12%
2016-06-30 $10.34B $3.74B 36.15%
2016-03-31 $10.65B $3.97B 37.27%
2015-12-31 $10.45B $4.14B 39.63%
2015-09-30 $9.91B $4.24B 42.74%
2015-06-30 $9.18B $4.20B 45.74%
2015-03-31 $8.49B $3.90B 45.98%
2014-12-31 $8.21B $3.69B 44.91%
2014-09-30 $8.05B $3.36B 41.69%
2014-06-30 $7.53B $2.28B 30.25%
2014-03-31 $6.59B $2.00B 30.33%
2013-12-31 $5.77B $1.70B 29.39%
2013-09-30 $4.63B $1.28B 27.67%
2013-06-30 $3.97B $1.47B 37.10%
2013-03-31 $3.69B $1.29B 34.86%
2012-12-31 $3.48B $1.10B 31.67%
2012-09-30 $3.21B $1.08B 33.50%
2012-06-30 $2.93B $1.08B 36.94%
2012-03-31 $2.72B $1.02B 37.60%
2011-12-31 $2.43B $0.94B 38.73%
2011-09-30 $2.29B $0.83B 36.24%
2011-06-30 $1.90B $0.47B 24.83%
2011-03-31 $1.53B $0.31B 20.37%
2010-12-31 $1.18B $0.17B 14.04%
2010-09-30 $0.91B $0.17B 18.61%
2010-06-30 $0.91B $0.35B 38.23%
2010-03-31 $0.87B $0.30B 34.56%
2009-12-31 $0.82B $0.32B 38.86%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $3.597B $8.757B
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $20.902B 7.10
Dr Reddy's Laboratories (RDY) India $12.399B 18.57
BridgeBio Pharma (BBIO) United States $4.791B 0.00
Amphastar Pharmaceuticals (AMPH) United States $2.469B 13.82
Supernus Pharmaceuticals (SUPN) United States $1.872B 377.44
Taysha Gene Therapies (TSHA) United States $0.314B 51.00
Personalis (PSNL) United States $0.270B 0.00
Assembly Biosciences (ASMB) United States $0.107B 0.00
Acasti Pharma (GRCE) Canada $0.031B 0.00
Sol-Gel Technologies (SLGL) Israel $0.014B 0.00
Evoke Pharma (EVOK) United States $0.005B 0.00
Teligent (TLGT) United States $0.000B 0.00